Complete Recovery from Recurrent Metastatic Cervical Cancer

A 55-year-old woman with a sustained, complete recovery shares her story about resuming her life after recurrent metastatic cervical cancer. Axalimogene filolisbac is an investigational drug. These patient results may not be typical. Further study is warranted and is underway.

Surviving to See the Milestones of Life

One woman’s story of a partial response from metastatic cervical cancer in a clinical trial with axalimogene filolisbac, Advaxis’ lead product candidate for HPV-related cancers. Axalimogene filolisbac is an investigational drug. These patient results may not be typical. Further study is warranted and is underway.

A Return to Active Life after Immunotherapy and Surgery

A 48-year-old man recovers from Head and Neck cancer through participation in a clinical trial using axalimogene filolisbac. Axalimogene filolisbac is an investigational drug. These patient results may not be typical. Further study is warranted and is underway.